Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Nurexone Biologic Inc (NRX.VN)
Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,739
  • Shares Outstanding, K 55,342
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,169 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 39.58
Trade NRX.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.03 on N/A
  • Latest Earnings Date 04/04/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.290 +141.38%
on 02/02/24
1.190 -41.18%
on 02/20/24
+0.395 (+129.51%)
since 02/01/24
3-Month
0.260 +169.23%
on 01/15/24
1.190 -41.18%
on 02/20/24
+0.385 (+122.22%)
since 12/01/23
52-Week
0.100 +600.00%
on 04/14/23
1.190 -41.18%
on 02/20/24
+0.350 (+100.00%)
since 03/01/23

Most Recent Stories

More News
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 47.29 (-1.17%)
TAK : 14.56 (-0.21%)
NRX.VN : 0.700 (+14.75%)
BMY : 50.89 (+0.28%)
NRX : 0.14 (+7.69%)
When Technicals and Fundamentals Converge, A Nice Uptrend Ensues

Some investors only pay attention to fundamentals. Others put more weight on technical charts. Another way of looking at it is to think of technical as being useful for quick decisions for those good at...

RIO : 65.14 (+0.95%)
NRDS : 16.91 (+0.24%)
NOA.TO : 34.36 (+1.12%)
NRX.VN : 0.700 (+14.75%)
NOA : 25.35 (+1.28%)
NRX : 0.14 (+7.69%)
24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury

An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...

TECH : 74.38 (+1.10%)
LLY : 782.12 (+3.77%)
CAPR : 4.57 (+8.69%)
NRX.VN : 0.700 (+14.75%)
NRX : 0.14 (+7.69%)
PARS : 0.0200 (-48.72%)
NurExone Announces Appointment of New Director and Provides Corporate Updates

Toronto, Ontario and Tel Aviv, Israel--(Newsfile Corp. - July 7, 2023) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) ("NurExone" or the "Company") is pleased to announce that, effective July...

NRX.VN : 0.700 (+14.75%)
NurExone Engages Investor Relations Service Provider

Toronto, Ontario and Tel Aviv, Israel--(Newsfile Corp. - May 12, 2023) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided...

NRX.VN : 0.700 (+14.75%)
NurExone Announces Equity Incentive Plan Grants and Director Resignation

Toronto, Ontario and Tel Aviv, Israel--(Newsfile Corp. - May 8, 2023) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided...

NRX.VN : 0.700 (+14.75%)
United States Patent Office Allows Patent to Exosome Biomedical Company NurExone

The patent covers NurExone's ExoPTEN drug compositions and treatment methods for Central Nervous System diseaseHaifa, Israel and Calgary, Alberta--(Newsfile Corp. - January 12, 2023) - NurExone Biologic...

NRX.VN : 0.700 (+14.75%)
NurExone Biologic Inc Named an Emerging Leader in Exosome-Based Treatment of Spinal Cord Injury

Background Each year, hundreds of thousands of people suffer from spinal cord injury. In addition, poor medical care and the lack of availability of effective treatments contribute to an increase in SCI...

NRX.VN : 0.700 (+14.75%)
NurExone Biologic Inc. Opens the Market

/CNW/ - Representatives from NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX) and their team joined Yossi Boker, TMX Head of Business...

NRX.VN : 0.700 (+14.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.890
2nd Resistance Point 0.800
1st Resistance Point 0.750
Last Price 0.700
1st Support Level 0.610
2nd Support Level 0.520
3rd Support Level 0.470

See More

52-Week High 1.190
Fibonacci 61.8% 0.774
Last Price 0.700
Fibonacci 50% 0.645
Fibonacci 38.2% 0.516
52-Week Low 0.100

See More

Business Summary

NurExone Biologic Inc is engaged in the development of novel, biological and minimal-invasive treatments for Spinal Cord Injury and Traumatic Brain Injury.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar